Trial Profile
Retrospective study of double dose of Lopinavir/Ritonavir along with rifampicin in treatment of tuberculosis-HIV co-infected patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Rifampicin/isoniazid/pyrazinamide/ethambutol
- Indications HIV infections; Tuberculosis
- Focus Adverse reactions; Therapeutic Use
- 26 Nov 2015 New trial record